Novel potent σ1 ligands: N-[ω-(tetralin-1-yl)alkyl]piperidine derivatives

Journal of Medicinal Chemistry

Volumn 39, Issue 21, 1996, Pages 4255-4260

  Berardi, Francesco ^a   Giudice, Giuseppe ^a   Perrone, Roberto ^a   Tortorella, Vincenzo ^a   Govoni, Stefano ^b   Lucchi, Laura ^c  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAZOCINE; PHENCYCLIDINE; PIPERIDINE DERIVATIVE; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; TETRALIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; HIPPOCAMPUS; KETANSERIN; PHENCYCLIDINE; PIPERIDINES; RATS; RECEPTORS, PHENCYCLIDINE; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SIGMA; SPIPERONE; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDRONAPHTHALENES;

EID: 0029797079     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9508898     Document Type: Article

References (41)

1. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; de Costa, B.; Rice, K. C. Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42, 355-402.
2. Abou-Gharbia, M.; Ablordeppey, S. Y.; Glennon, R. A. Sigma Receptors and their Ligands: The Sigma Enigma. Annu. Rep. Med. Chem. 1993, 28, 1-10.
3. Wyrick, S. D.; Booth, R. G. Progress in sigma receptor research. Drugs Future 1995, 20, 1033-1044.
4. Vilner, B. J.; De Costa, B. R.; Bowen, W. D. Cytotoxicity of sigma ligands: Sigma receptor-mediated effects on cellular morphology and viability. J. Neurosci. 1995, 15, 117-134.
5. Steardo, L.; Monteleone, P.; d'Istria, M.; Serino, I.; Maj, M.; Cuomo, V. (+)-N-Allylnormetazocine Enhances N-Acethyltransferase Activity and Melatonin Synthesis: Preliminary Evidence for a Functional Role of Sigma Receptors in the Rat Pineal Gland. J. Pharmacol. Exp. Ther. 1995, 275, 845-849.
6. 3H]-noradrenalin release in rat hippocampus: G-protein dependency. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 346, 32-39.
7. Nakagawara, M.; Sato, Y. Neuropeptide Y: Psychopharmacological and clinical aspects. Yakubutsu-Seishin-Kodo 1994, 14, 117-127.
8. Bouchard, P.; Dumont, Y.; Fournier, A.; St. Pierre, S.; Quirion, R. Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in mouse hippocampal formation. J. Neurosci. 1993, 13, 3926-3931.
9. Gilligan, P. J.; Tam, S. W. Sigma receptor ligands: potential drugs for the treatment of CNS disorders? Drugs News Perspect. 1994, 7, 13-18.
10. Debonnel, G. Current Hypotheses on Sigma Receptors and Their Physiological Role: Possible Implications in Psychiatry. J. Psychiatr. Neurosci. 1993, 18, 157-172.
11. Gerwirtz, G. R.; Gorman, J. M.; Volavka, J.; Macaluso, J.; Gribkoff, G.; Taylor, D. P. BMY-14802, a sigma receptor ligand for the treatment of schizophrenia. Neuropsychopharmacology 1994, 10, 37-40.
12. Menkel, M.; Pontecorvo, M.; Katz, J.; Witkin, J. M. Selective σ ligands block stimulant effects of cocaine. Eur. J. Pharmacol. 1991, 201, 251-252.
13. Izenwasser, S.; Hauck Newman, A.; Katz, J. L. Cocaine and several σ receptor ligands inhibit dopamine uptake in rat caudate-putamen. Eur. J. Pharmacol. 1993, 243, 201-205.
14. Taylor, D. P.; Yevich, J. P.; Dextraze, P.; Moon, S. L.; Behling, S. H.; Defnet, J.; Geissler, M. In Multiple Sigma and PCP Receptor Ligands: Mechanism for Neuromodulation and Neuroprotection? Kamenka, J.-M., Domino, E. F., Ed.; NPP Books: Ann Arbor, MI, 1992; pp 767-778.
15. De Loore, K. L.; Lesage, A. S.; Peeters, L.; Leysen, J. E. Various sigma ligands exert long-term protection against glutamate toxicity in primary hippocampal neurones; apparent non involvement of identified sigma-2 sites. Neurosci. Res. Commun. 1994, 14, 43-52.
16. Lehmann, J. Sigma Receptor, Schizophrenia and Cytochrome P-450. Drugs News Perspect. 1991, 4, 208-210.
17. Largent, B. L.; Wikström, H.; Gundlach, A. L.; Snyder, S. H. Structural Determinants of σ Receptor Affinity. Mol. Pharmacol. 1987, 32, 772-784.
18. Quirion, R.; Bowen, W. D.; Itzhak, Y.; Junien, J. L.; Musacchio, J. M.; Rothman, R. B.; Su, T.-P.; Tam, S. W.; Taylor, D. P. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13, 85-86.
19. 1 Receptor Binding. J. Med. Chem. 1994, 37, 1214-1219.
20. He, X.; Bowen, W. D.; Lee, K. S.; Williams, W.; Weinberger, D. R.; de Costa, B. R. Synthesis and Binding Characteristics of Potential SPETC Imaging Agents for σ-1 and σ-2 Binding Sites. J. Med. Chem. 1993, 36, 566-571.
21. de Costa, B. R.; He, X.; Dominguez, C.; Cutts, J.; Williams, W.; Bowen, W. D. A New Approach to the Design of σ-2 Selective Ligands: Synthesis and Evaluation of N-[2-(3,4-Dichlorophenyl)-ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine-Related Polyamines at σ-1 and σ-2 Receptor Subtypes. J. Med. Chem. 1994, 37, 314-321.
22. Hudkins, R. L.; Mailman, R. B.; DeHaven-Hudkins, D. L. Novel (4-Phenylpiperidinyl)- and (4-Phenylpiperazinyl)alkyl- Spaced Esters of 1-Phenylcyclopentanecarboxylic Acids as Potent σ-Selective Compounds. J. Med. Chem. 1994, 37, 1964-1970.
23. Gilligan, P. J.; Cain, G. A.; Christos, T. E.; Cook, L.; Drummond, S.; Johnson, A. L.; Kergaye, A. A.; McElroy, J. F.; Rohrbach, K. W.; Schmidt, W. K.; Tam, S. W. Novel Piperidine σ Receptor Ligands as Potential Antipsychotic Drugs. J. Med. Chem. 1992, 35, 4344-4361.
24. 1A Receptor Ligands: ω-(Tetralin-1-y1)-n-alkylamine Derivatives. J. Med. Chem. 1996, 39, 176-182.
25. Glennon, R. A.; Yousif, M. Y.; Ismaiel, A. M.; El-Ashmawy, M. B.; Herndon, J. L.; Fischer, J. B.; Server, A. C.; Burke Howie, K. J. Novel 1-Phenylpiperazine and 4-Phenylpiperidine Derivatives as High-Affinity σ Ligands. J. Med. Chem. 1991, 34, 3360-3365.
26. Ablordeppey, S. Y.; Fischer, J. B.; Burke Howie, K. J.; Glennon, R. A. Design, Synthesis and Binding of Sigma Receptor Ligands derived from Butaclamol. Med. Chem. Res. 1992, 2, 368-375.
27. Russell, M. G. N.; Baker, R.; Billington, D. C.; Knight, A. K.; Middlemiss, D. N.; Noble, A. J. Benz[f]isoquinoline Analogues as High-Affinity σ Ligands. J. Med. Chem. 1992, 35, 2025-2032.
28. Chambers, M. S.; Baker, R.; Billington, D. C.; Knight, A. K.; Middlemiss, D. N.; Wong, E. H. F. Spiropiperidines as High-Affinity, Selective σ Ligands. J. Med. Chem. 1992, 35, 2033-2039.
29. Gilligan, P. J.; Kergaye, A. A.; Lewis, B. M.; McElroy, J. F. Piperidinyltetralin σ Ligands. J. Med. Chem. 1994, 37, 364-370.
30. El-Ashmawy, M.; Ablordeppey, S. Y.; Issa, H.; Gad, L.; Fischer, J. B.; Burke Howie, K. J.; Glennon, R. A. Further investigation of 5-phenylpentylamine derivatives as novel sigma receptor ligands. Med. Chem. Res. 1992, 2, 119-126.
31. 1A Receptor of 1-Aryl-4-[(1-tetralin)alkyl]piperazines. 2. J. Med. Chem. 1995, 38, 942-949.
32. 1A/D-2 Activity of a New Model of Arilpiperazines: 1-Aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and Structure-Activity Relationships. J. Med. Chem. 1994, 37, 99-104.
33. 1 receptors. Eur. J. Pharmacol. 1994, 266, 131-138.
34. 1C Binding Sites in Rat Frontal Cortex. J. Neurochem. 1986, 47, 529-540.
35. 1A receptors. Eur J. Pharmacol. 1988, 149, 107-120.
36. 3H]phencyclidine binding in rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 5372-5376.
37. 3H]-spiroperidol on rat striatal membranes. Eur. J. Pharmacol. 1978, 50, 283-294.
38. Lucchi, L.; Moresco, M. R.; Govoni, S.; Trabucchi, M. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum. Brain Res. 1988, 449, 347-351.
39. Munson, P. J.; Rodbard, D. Ligand: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 1980, 107, 220-239.
40. 3H]tolyl)guanidine a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 8784-8788.
41. Carroll, F. I.; Abraham, P.; Parham, K.; Bai, X.; Zhang, X.; Brine, G. A.; Mascarella, S. W.; Martin, B. R.; May, E. L.; Sauss, C.; Di Paolo, L.; Wallace, P.; Walker, J. M.; Bowen, W. D. Enantiomeric N-Substituted N-Normetazocines: A Comparative Study of Affinities at σ, PCP and μ Opioid Receptors. J. Med. Chem. 1992, 35, 2812-2818.